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PhenylephrineThis study investigated the participation of median raphe nucleus (MnR) α1-adrenergic receptors in the con-
trol of feeding behaviour. The α1-adrenergic agonist phenylephrine (PHE) and α2-adrenergic agonist cloni-
dine (CLON) (at equimolar doses of 0, 6 and 20 nmol) were injected into the MnR of: a) rats submitted to
overnight fasting (18 h); or b) rats maintained with 15 g of lab chow/day for 7 days. Immediately after the
drug injections, the animals were placed in the feeding chamber and feeding and non-ingestive behaviours
such as grooming, rearing, resting, snifﬁng and locomotion were recorded for 30 min. The results showed
that both doses of PHE injected into the MnR of overnight fasted animals decreased food intake accompanied
by an increase in the latency to start feeding. A reduction in feeding duration was observed only after treat-
ment of the MnR with the 20 nmol dose of PHE. Both locomotion duration and snifﬁng frequency increased
after injection with the highest dose PHE into the MnR. Feeding frequency and the other non-ingestive be-
haviours remained unchanged after PHE treatment in the MnR. Both doses of PHE injected into the MnR of
food-restricted rats decreased food intake. This hypophagic response was accompanied by a decrease in feed-
ing duration only after treatment of the MnR with the highest dose of PHE. The latency to start feeding and
feeding frequency were not affected by injection of either dose of PHE into the MnR. While both doses of
PHE increased snifﬁng duration, the highest dose of PHE increased resting duration and resting frequency.
Treatment with CLON into the MnR did not affect feeding behaviour in either of the food deprivation condi-
tions. The present results indicate the inhibitory functional role of α1-adrenergic receptors within the MnR
on feeding behaviour.+55 48 37219672.
(A.S. Ribas).
evier OA license.© 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The raphe nuclei are constituted of serotonergic neurons grouped
into eight nuclei located in the midline of the brainstem. These nuclei
are considered to be the main source of prosencephalic serotonin (5-
hydroxytryptamine) (5-HT) [1–4]. The dorsal raphe nucleus and the
median raphe nucleus (MnR) also contain distinct subpopulations of
non-serotonergic neurons that occur in equal or greater numbers
compared to the serotonergic neurons [5–9]. In the MnR, GABAergic
neurons are located in both midline and lateral regions across the ros-
tro-caudal extent of the MnR. 5-HT neurons are found just lateral and
adjacent to the population of GABAergic neurons at the midline with
little overlap or co-localisation between the two populations [10].
Non-serotonergic neurotransmitters are co-localised with serotoner-
gic neurotransmitters [10–14], and include gamma-amino butyric
acid (GABA), glutamate and corticotropin-releasing factor (CRF)[15–17]. Thus, both 5-HT and non-5-HT neurotransmitters may be
co-released within the raphe nuclei as well as in projection areas
[18,19]. It is estimated that 20% of the 5-HT innervations originating
in the MnR predominantly reach the dorsal hippocampus, medial
septum and hypothalamus [5,20].
A great density of 5-HT1A receptors is found in the MnR [21–24] and
they function as autoreceptors that regulate the synthesis and release of
5-HT in their projection areas [21,25]. Agonists of 5-HT1A receptors, such
as 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), stimulate
food intake when injected into theMnR [26–29]. Besides the high densi-
ty of 5-HT receptors in theMnR, a great density ofα1- andα2-adrenergic
receptors in this nucleus has been reported [30–32]. MnR neurons re-
ceive noradrenergic innervation from the locus coeruleus/subcoeruleus,
lateral tegmental area, and projections from the adrenaline (AD) (C1+
C2) medullary nuclei and A1/A2 cell groups [33–37]. The noradrenergic
inputs to MnR exert tonic facilitatory control of 5-HT release through
α1-adrenergic receptors and inhibitory control by α2-adrenergic recep-
tors [21,30].
Previous studies in our laboratory revealed AD but not noradrena-
line (NA) injected into the MnR decreased food intake and shortened
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tion of AD into the MnR of free-feeding rats increased food intake,
feeding frequency and decreased the latency to start feeding [39].
Since the inhibitory action of 5-HT on feeding behaviour has been ex-
tensively reported [25,40–43] and due to the serotonergic innerva-
tion of the hypothalamic paraventricular nucleus, an important
region where 5-HT has been implicated in feeding regulation arises
from MnR serotonergic projections [41,44,45]. We have suggested
that in food-restricted rats, AD-induced hypophagia may be due to
the activation of α1-adrenergic receptors on 5-HT MnR neurons
resulting in 5-HT release and an indirect inhibitory action of AD on
feeding [38]. In free-feeding rats, the food intake effects evoked by
AD injections may be attributed to the activation of α2-adrenergic re-
ceptors on 5-HTMnR neurons that could act to suppress the release of
5-HT and its inhibitory action on feeding behaviour [39].
This suggestion was reinforced by data showing that treatment with
clonidine (CLON), anα2-adrenergic agonist, into theMnRof free-feeding
rats resulted in a hyperphagic response with an intensity, duration as
well as frequency similar to that induced by AD [46]. In this case, an in-
hibitory inﬂuence activated by adrenergic inputs was removed due to
α2-adrenergic stimulation, which in turn decreased the concentration
of catecholamines in the synapse. The feeding behaviour effects induced
by CLON in theMnRwere speciﬁcallymediated byα2-adrenergic activa-
tion since previous injection of an α2-adrenergic antagonist into the
MnR blocked the hyperphagic response evoked by this drug [47]. In con-
trast, phenylephrine (PHE) treatment in the MnR failed to modify feed-
ing behaviour in rats with free access to food. This lack of change in the
feeding response after MnR α1-adrenergic receptor activation was at-
tributed to the presence of elevated adrenergic inputs on MnR neurons
which restrain food intake under free-feeding conditions [48]. This sug-
gestion was reinforced by data showing that α1-adrenergic receptor
blockade within the MnR increased food intake in free-feeding rats [47].
In order to strengthen the inhibitory functional role that α1-
adrenergic receptors within the MnR exert on food intake, the pre-
sent study was designed to evaluate the feeding behaviour effects
evoked by injection of α1-adrenergic receptor agonists into the
MnR of food-deprived animals since it has been reported that the in-
hibitory serotonergic tonus is lower in animals submitted to a food
restriction regimen than in free-feeding animals [49–51]. In addition,
the feeding effects caused by MnR α2-adrenergic receptor activation
were also investigated.2. Materials and methods
2.1. Animals and surgery
All the experimental procedures described below were conducted
in strict adherence to the recommendations found in the “Principles
of animal care” and were approved by the local Committee for Ethics
in Animal Research (CEUA-UFSC, protocol # PP00367). Male adult
Wistar rats (n=108) weighing 270–310 g at the time of surgery
were used in this study and were group-housed in a room at 21±
2 °C under a 12 h lighting cycle (lights on at 07:00 h) with free access
to food and water, except when food restriction was applied. The rats
were anesthetised with ketamine hydrochloride (100 mg/kg, i.p.) and
xylazine (20 mg/kg, i.p.) and were placed in a stereotaxic apparatus
(Insight Instruments, Ribeirão Preto, SP, BRA) for unilateral stainless
steel guide cannula (30 G) implantation according to the coordinates
(AP ±7.8, L ±3.0 and DV ±9.0) described by Paxinos and Watson
[52]. The guide-cannula was inserted at a lateral angle of 20° to
avoid the sagittal sinus, and cerebral aqueduct obstruction and was
aimed at 2 mm dorsal to the MnR. The cannula was anchored to the
skull with jeweller screws and ﬁxed with dental cement; the cannula
was maintained patent between experiments by an inner removable
stylet.2.2. Drugs and injections
Phenylephrine hydrochloride (6 and 20 nmol, purchased from
Sigma Chemical Co., St. Louis, MO, USA) and clonidine hydrochloride
(6 and 20 nmol, purchased from Tocris Bioscience, Ellisville, MO,
USA) were freshly dissolved in 0.9% saline, which was used as the ve-
hicle in control experiments. The drug injections were made through
an inner cannula (33 G) that extended 2 mm beyond the tip of the
guide cannula connected by polyethylene tubing (PE10) to a Hamilton
microsyringe (1 μl) ﬁtted to an injection pump. The injected volumes
(0.2 μl) were administered over a period of 60 s and a further 60 s
was allowed for the solution to diffuse from the cannula. The drug
doses used in the experiments were derived from our previous studies
[38,39,46,47].
2.3. Experimental procedures
For 1 week after surgery, the rats were housed individually with
free access to food and water. After this period, the animals were sep-
arated into two experimental groups. 1) Food-restricted rats: in this
group, the animals were submitted to a food restriction regimen
whereby the daily food allotment was limited to 15 g of laboratory
chow, delivered at 17:00 h for 7 days. The rats continued to have free
accesses to water. After 4 days of food restriction, the body weight de-
clined by approximately 10% and remained stable until the day of the
experiment. The experimental session began on the eighth day of
food restriction. The rats were habituated, on two occasions before
the experiments, to the handling and injection procedures. During
the habituation, the rats received mock injections to allow acclimation
to the microinfusion procedures. No solutions were delivered on mock
injection days by an inner cannula that exhibited the same guide can-
nula length. The rat chow not consumed at the end of the habituation
sessions was offered to the animals at 17:00 h, in order to complete
15 g of chow pellets/day. 2) Overnight fast (18 h): in this group the an-
imals were deprived of food overnight and the morning prior to all ex-
periments (18 h), but continued to have free accesses to water. Each
animal received only one drug treatment. All procedures were carried
out between 13:00 h and 16:30 h. Immediately after the drug injection
into the MnR, the rats were placed in the recording chamber con-
structed with transparent glass (49×34×32 cm), containing food and
tap water (in a bottle placed outside the test cage with a spout pro-
jected through the wall of the cage). The session was recorded by a
webcam perpendicularly located 60 cm above the cage ﬂoor for subse-
quent detailed behavioural analysis through Etholog 2.2 [53]. The back
and lateral walls, as well as the ﬂoor cage, were coated with a black ad-
hesive plastic paper. In order to facilitate behavioural recording, the
front wall of the test cage had a mirror with the same dimensions ar-
ranged at a 45° angle in relation to the vertical plane. This mirror ar-
rangement also prevented the animal from seeing its reﬂection in the
mirror. At the end of the recording period, any food that occasionally
spilled on the cage ﬂoor was recovered and weighed with the food
that remained in the feeder. The difference between food or water
weight at the beginning and at the end of the recording period was
taken as the amount of food or water consumed. During the 30 min ex-
perimental session, the ingestive behaviours such as the latency to start
feeding and drinking, the feeding and drinking duration, as well as the
feeding and drinking frequency were evaluated. The duration and fre-
quency of ﬁve non-ingestive behaviours (grooming, locomotion, rear-
ing, resting and snifﬁng) were also assessed. The behaviour duration
assessed in this study represents the sum of each episode occurred dur-
ing the experimental session. All behaviour categories were deﬁned in
previous studies [54] and are described in Table 1.
An additional experimental group (experiment 3)was carried out in
order to conﬁrm whether the PHE effects on feeding behaviour were
site-speciﬁc. In this group, the PHE dose that evoked feeding behaviour
changes in experiments 1 and 2was injected into areas in the vicinity of
Table 1
The behavioural categories used for behavioural analysis.
Based on Halford and Blundell [54].
Category Description
Eating (food intake) Biting, gnawing or swallowing food from wet mash dish
directly or from front paws.
Drinking (water intake) Licking the spout water bottles.
Grooming Licking of the body, feet, and genitals. Scratching of coat
or head with hind leg. Stroking whiskers with paws.
Biting of the tail.
Locomotion Walking around the cage or circling. Movements'
involving all four paws.
Rearing Front paws raised from the tank ﬂoor and either placed
on the side of the tank or placed in front of the body.
Snifﬁng Rapid wrinkling of nose (twitching of vibrissae) directed
at some aspect of the environment. Head movement.
Rear limbs immobile.
Resting Animal inactive. Relaxed position with head curled to
body or resting on the bottom of the cage, stretched
out either on side or belly.
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paramedia raphe nucleus (PMnR) reticulotegmental nucleus pons
(RtTg), trigeminothalamic tract (tth), medial leminuscus (ml), and the
feeding behaviour of both food-restricted and overnight fasted rats
was evaluated.
2.4. Histological analysis
At the end of the experiments, the animals were deeply anaesthe-
tised and transcardially perfused with 0.9% saline, followed by 10%
formalin. The brains were removed and subsequently cut (on a vibra-
tome) in the transverse plane (100 μm thick sections). Sections were
stained with cresyl violet and the cannula loci were examined and
documented through a camera lucida attached to a light microscope.
Cannula placements were mapped onto the corresponding atlas
drawings of Paxinos and Watson [52]. Data from the rats with mis-
placed cannulae in the MnR were not included in the analyses.
2.5. Statistical analysis
Separate one-wayANOVA testswere carried out to analyse the food-
restricted data, for the different doses of PHE or CLON (0, 6 and
20 nmol). The same statistical procedures were employed for data ana-
lyses of the overnight fast group. The effects of treatmentwith saline (0)
or PHE (20 nmol) in the MnR and non-median raphe nucleus (Pn, PnO,
PMnR, RtTg, tth and ml) were analysed by two-way ANOVA (drug-
dose×injected area). All these tests were followed, when appropriate,
by Duncan's post-hoc test, and a pb0.05 was accepted as being statisti-
cally signiﬁcant in these procedures. All statistical procedureswere per-
formed using the Statistica 9 software forWindows (StatSoft, Tulsa, OK,
USA).
3. Results
Fig. 1 illustrates the injection sites within the MnR in coronal sec-
tions of the brain. Histological analysis indicated that 77 points of in-
jection were within the MnR distributed between AP−7.44 mm and
AP−8.40 mm. The misplaced injection sites included points in the Pn
(n=11), Pno (n=10), RtTg (n=4), PMnR (n=2), tth (n=2) andml
(n=2).
3.1. Experiment 1: food-restricted rats (15 g chow/day for 7 days) —
drug dose effects on ingestive and non-ingestive behaviours
The one-way ANOVA test revealed that food intake was affected
by the drug PHE [F (2,18)=10.36; pb0.001]. Duncan's test revealedthat both doses of PHE (6 and 20 nmol) injected into the MnR of
food-restricted rats decreased food intake when compared with the
control group. This hypophagic effect was accompanied by a decrease
in feeding duration [F (2,18)=3.65; pb0.046] only after treatment of
the MnR with the highest dose of PHE (Fig. 2). The latency to start
feeding and the feeding frequency were not affected by injections of
either dose of PHE into the MnR (Fig. 2). Drinking behaviour was
also not modiﬁed by PHE treatment (Table 2). Except for resting
and snifﬁng behaviours, the other non-ingestive behaviours did not
change after PHE administration into the MnR. The highest dose of
PHE (20 nmol) increased resting duration [F (2,18)=5.27; pb0.015]
and resting frequency [F (2,18)=3.69; pb0.045] (Table 3). Both
PHE doses increased snifﬁng duration [F (2,18)=4.76; pb0.021]
(Table 3). Feeding (Fig. 3), drinking (Table 2) and non-ingestive be-
haviours remained unchanged after administration of both doses of
CLON into the MnR (Table 3).
3.2. Experiment 2: overnight fast group — drug dose effects on ingestive
and non-ingestive behaviours
The one-way ANOVA test demonstrated that both food intake
[F (2,16)=17.56; pb0.00009] and the latency to start feeding
[F (2,16)=3.81; pb0.044] were signiﬁcantly affected by PHE treatment
in the MnR. Feeding duration was marginally affected by PHE [F (2,16)
=3.30; pb0.062]. Food intake decreased after injection of both doses of
PHE into the MnR of overnight fasted rats (Fig. 4). This hypophagic re-
sponse was evoked by both doses of PHE and was accompanied by an
increase in the latency to start feeding (Fig. 4). A reduction in feeding
duration was observed only after treatment of the MnR with the
20 nmol dose of PHE (Fig. 4). Drinking behaviour was not modiﬁed by
PHE treatment (Table 2). Non-ingestive behaviours remained
unchanged after the administration of both doses of PHE into the MnR
(Table 4), except for locomotion duration, whichwasmarginally affect-
ed by the drug [F (2,16)=3.19; pb0.067], and snifﬁng frequencywhich
was signiﬁcantly affected by PHE treatment [F (2,16)=6.83; pb0.007].
Both locomotion duration and snifﬁng frequency increased after injec-
tion of the highest dose PHE into the MnR (Table 4). Treatment of the
MnR with both doses of CLON did not change feeding (Fig. 5), drinking
(Table 2) and non-ingestive behaviours of overnight fasted rats
(Table 4).
3.3. Experiment 3: PHE injections into the vicinity of the MnR
The highest dose of PHE (20 nmol) injected into the MnR of both
food-restricted rats and overnight fasted rats, which had evoked a de-
crease in food intake, was also administered to other regions in the vi-
cinity of the MnR (Pn, PnO, PMnR, RtTg, tth, ml). These injections sites
were grouped as the non-median raphe region and food intake data
after PHE treatment were used to conﬁrm the speciﬁcity of the MnR
as the site of PHE injections that evoke a hypophagic response. The
two-way ANOVA test revealed that the food intake exhibited by food-
restricted rats was affected by the drug [F (1,26=10.40; p=0.003)]
and there was also a signiﬁcant interaction between the drug and the
injection site [F (1,26=11.89; p=0.001)]; in addition, the food intake
response exhibited by overnight fasted rats was signiﬁcantly affected
by the drug [F (1,26=7.24; p=0.012)] and there was also a signiﬁcant
interaction between the drug and the injection site [F (1,26=14.20;
p=0.0008)]. The food intake decrease evoked by the highest dose of
PHE was circumscribed to the MnR in both food-restricted and over-
night fasted rats (Fig. 6).
4. Discussion
The results of the present study revealed that while the injection
of PHE into the MnR decreased food intake in both food-deprived
conditions, treatment with CLON in the MnR did not affect feeding
Fig. 1. Photomicrographs and schematic drawings of coronal sections through the median raphe nucleus (MnR) of the rats, illustrating the approximate sites (●) of phenylephrine
(PHE)/clonidine (CLON) injections (at doses of 0, 6 and 20 nmol), and (★) phenylephrine (PHE) injections into the vicinity of the MnR. Arrows point to injection sites. Numbers at
the top refer to anteroposterior stereotaxic coordinates from the rat brain atlas (Adapted from Paxinos andWatson, 2007). Scale bar=100 μm. DRV= dorsal raphe nu, ventral part;
isRt = isthmic reticular formation; lfp = longitudinal fasciculus pons; mlf = medial longitudinal fasciculus; MnR = median raphe nucleus; PnO = Pontine reticular nu, oral part;
RtTg = reticulotegmental nu pons; ts = tectospinal tract; tth = trigeminothalamic tract; VTg = ventral tegmental nu; xscp = decussation sup cerebellar peduncle.
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diated by α1-adrenergic receptors within MnR, since treatment
with the highest dose of PHE, which decreased food intake when ad-
ministered into the MnR, did not change the feeding response when
injected into the vicinity of the MnR. Opposite feeding responses
were induced by the injection of α-adrenergic receptor agonists
into the MnR of free-feeding rats. CLON injection into the MnR
evoked hyperphagia while the PHE treatment did not change feeding
behaviour [46,48].
Based on these results, we suggest that the hyperphagic effect
evoked by CLON in free-feeding rats could be attributed to the inhi-
bition of NA release from presynaptic stores, thus removing the α1-
adrenergic stimulatory tone on serotonergic neurons within the
MnR, since α2-adrenergic receptors seem to exert a tonic inhibitory
inﬂuence on 5-HT release in the MnR [30]. The absence of feeding ef-
fects after treatment with PHE in the MnR of free-feeding rats could
be due to elevated adrenergic inputs on serotonergic neurons
[39,48]. It seems that the reduction of an adrenergic inhibitory inﬂu-
ence in food-deprived rats allows for α1-adrenergic receptor activa-
tion by PHE, resulting in 5-HT release, since facilitatory control of
5-HT release is attributed to α1-adrenoceptors [21,30] situated on
MnR serotonergic cell bodies [55]. In agreement with this sugges-
tion, we have recently reported [47] that the blockade of α1-adrenergic receptors within the MnR of free-feeding rats resulted
in hyperphagia accompanied by a reduction in the latency to start
eating, an increase in feeding duration and an increase in feeding fre-
quency. These data suggest the presence of tonic inhibitory inputs
mediated by α1-adrenergic receptors on MnR neurons that restrain
food intake under free-feeding conditions. The 5-HT released by
MnR α1-adrenergic receptor activation could inhibit food intake
through projections that terminate in the prosencephalic areas in-
volved in the control of food intake such as the hypothalamus or
amygdala [56–59].
It is estimated that 60% of MnR neurons are non-serotonergic [60]. It
is possible that GABAergic or glutamatergic neurotransmission in the
MnR [10,13,61] could be an alternative mechanisms involved in the
hypophagic response evoked by PHE in food-deprived rats, since
intra-MnR injection of muscimol [1,62,63] and baclofen [1] or the gluta-
matergic agonist (NMOLDA) [64] and glutamatergic antagonists
(kynurenic acid and 2-amino-5-phosphonovaleric acid) increased food
intake in free-feeding rats [65]. Raphe/neurokinin pathways could also
mediate the feeding effects induced by PHE treatment in the MnR
since the activation of neurokinin-3 (NK-3) receptors located on MnR
serotonin cell bodies has been shown to decrease food intake [63].
Except for the latency to start feeding, the hypophagic response
evoked by PHE injections into the MnR of overnight fasted rats
Fig. 2. Changes on food intake, feeding latency, feeding duration and feeding frequency after injection of vehicle (0) or phenylephrine (PHE, 6 nmol and 20 nmol) into themedian
raphe nucleus (MnR) of food restricted rats (15 g chow/day during 7 days). Values are mean±S.E.M. *pb0.05 as compared to vehicle treatment (one-way ANOVA followed by
Duncan's test for multiple comparisons). Numbers in parentheses indicate the number of animals per group.
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food-restricted rats. The feeding duration decreased after the injec-
tion of the highest PHE dose into the MnR and feeding frequency
was not affected by PHE treatment. In contrast, the latency to start
feeding remained unchanged after treatment with PHE in the MnR
of food-restricted rats, while both doses of PHE delayed the initia-
tion of feeding in the overnight fasted rats. Feeding duration and
the latency to start eating have been associated with different as-
pects of the control of feeding [66]. Changes in the latency to begin
feeding may be associated with changes in satiety mechanisms orTable 2
Drinking behaviour after injection of phenylephrine (PHE) and clonidine (CLON) into the m
night fast rats during 30 min. The number of animals used in each drug dose is illustrated i
Behaviour Food restricted rats
PHE CLON
Water intake 0 0.0±0.0 0.25±
6 0.08±0.08 0.50±
20 0.12±0.81 0.3±
0 1800.0±116.1 1577.7±
Latency (s) 6 1745.6±125.5 1435.9±
20 1547.0±108.7 1639.4±
0 0.0±0.0 4.0±
Duration (s) 6 0.79 ±0.79 5.2±
20 10.6±10.1 15.8±
0 0.0±0.0 0.8±
Frequency (turn) 6 0.3±0.3 1.2±
20 1.2±1.1 1.2±
Values are mean±S.E.M.in the processing of those signals that inhibit eating between feed-
ing. In this sense, the inﬂuence of MnR α1-adrenergic receptors on
satiety mechanisms was presented only in the overnight fasted but
not in the food-restricted rats. The reason for these discrepancies
could be attributed to metabolic/hormone changes or patterns of
orexigenic/anorexigenic neuropeptide gene expression associated
with adaptations to a food restriction regimen [67–70]. On the
other hand, changes in the feeding duration seemed to relate to sati-
ation processes, or themechanisms set inmotion by nutrient-related
signals that cause the end of a feeding bout. In this sense, we couldedian raphe nucleus (MnR) of food restricted (15 g chow/day during 7 days) and over-
n Figs. 2–4.
Overnigh fast
PHE CLON
0.1 0 0.1±0.1 0.08±0.08
0.2 6 0.0±0.0 0.3±0.3
0.2 20 0.1±0.1 0.2±0.2
138.4 0 1681.3±106.4 1627.4±263.7
138.4 6 1800.0±114.9 1405.0±244.2
138.4 20 1632.0±114.9 1296.8±263.7
2.7 0 2.2±1.5 0.3±0.3
3.9 6 0.0±0.0 1.4±0.8
14.7 20 3.0±1.9 0.9±0.6
0.5 0 0.4±0.3 0.2±0.2
0.8 6 0.0±0.0 0.4±0.2
0.8 20 0.6±0.6 0.3±0.2
Table 3
Duration of non-ingestive behaviours 30 min after injection of vehicle (0) phenylephrine (PHE) or clonidine (CLON) into the median raphe nucleus of food restricted rats (15 g
chow/day during 7 days). The number of animals used in each drug dose is illustrated in Figs. 2 and 3.
Behaviour Phenylephrine (PHE) Clonidine (CLON)
Dose
(nmol/0.2 μl)
Duration (s) Frequency
(turn number/30 min)
Dose
(nmol/0.2 μl)
Duration (s) Frequency
(turn number/30 min)
Locomotion 0 124.8±19.4 33.4±4.1 0 231.2±48.7 60.5±8.7
6 158.2±30.2 42.3±9.3 6 180.7±42.5 48.5±12.5
20 125.4±29.9 30.5±8.3 20 170.6±19.1 42.8±5.4
0 8.1±4.3 2.7±1.6 0 10.4±5.5 2.8±1.3
Resting 6 10.0±6.4 1.8±0.7 6 22.8±15.1 3.5±1.6
20 115.6±40.9* 8.5±2.4* 20 61.9±36.7 3.3±2.6
0 57.8±11.7 18.8±2.7 0 86.8±15.8 36.6±7.9
Rearing 6 101.8±29.7 26.6±7.8 6 105.6±24.7 29.7±5.9
20 39.5±11.8 15.5±4.8 20 84.5±15.9 25.2±4.0
0 70.6±13.6 20.2±3.8 0 99.9±13.5 32.0±3.8
Snifﬁng 6 151.2±30.0* 29.6±4.1 6 155.9±43.6 35.5±9.0
20 159.8±23.1* 25.5±4.7 20 132.5±25.5 29.5±3.6
0 16.4±4.2 2.2±0.4 0 35.7±10.3 4.5±1.4
Grooming 6 31.9±4.5 4.0±0.4 6 61.0±13.9 4.5±1.1
20 50.0±15.9 4.7±1.6 20 74.0±24.0 5.2±1.6
Values are mean±S.E.M. *pb0.05 as compared to the vehicle treatment (one-way ANOVA followed by Duncan's post-hoc test).
225A.S. Ribas et al. / Physiology & Behavior 105 (2012) 220–229suggest that α1-adrenergic receptors in the MnR can be associated
with neural circuits involved in satiation induced by signals arising
from the digestive tract [71–74], characterised in this study by a re-
duction in the meal size and shortening feeding duration in both
food-restricted and overnight fasted rats.
The hypophagia evoked by PHE injection into the MnR of 7-day
food-restricted rats could be attributed to an increase in the durationFig. 3. Changes on food intake, feeding latency, feeding duration and feeding frequency after
nucleus (MnR) of food restricted rats (15 g chow/day during 7 days). Values are mean±S.Eof snifﬁng behaviour, an indication of ambient exploration. This in-
crease in exploratory behaviour induced by both doses of PHE could
have interfered with the feeding response such that the animal
stopped eating not because he was satiated, but because the drug
could have stimulated a different behaviour such as exploration.
However, the noticeable increase in resting (or sleep-like) behaviour
after PHE injection into the MnR may be interpreted as an integral partinjection of vehicle (0) or clonidine (CLON, 6 nmol and 20 nmol) into the median raphe
.M. Numbers in parentheses indicate the number of animals per group.
Fig. 4. Changes on food intake, feeding latency, feeding duration and feeding frequency after injection of vehicle (0) or phenylephrine (PHE, 6 nmol and 20 nmol) into the median
raphe nucleus (MnR) of overnight fast. Values are mean±S.E.M. *pb0.05 as compared to vehicle treatment (one-way ANOVA followed by Duncan's test for multiple comparisons).
Numbers in parentheses indicate the number of animals per group.
226 A.S. Ribas et al. / Physiology & Behavior 105 (2012) 220–229of the normal behavioural satiety sequence (feeding–maintenance–
resting) [54,75,76]. Furthermore, the highest dose of PHE injected into
theMnR of overnight fasted rats evoked an increase in both the snifﬁng
frequency andduration of locomotion, but the lowest PHEdose evoked a
hypophagic response with no changes in non-ingestive behaviours.Table 4
Duration of non-ingestive behaviours 30 min after injection of vehicle (0) phenylephrine (PH
animals used in each drug dose is illustrated in Figs. 4 and 5.
Behaviour Phenylephrine (PHE)
Dose
(nmol/0.2 μl)
Duration (s) Frequency
(turn number/30 m
Locomotion 0 181.8±14.6 50.8±5.5
6 230.1±12.3 52.6±4.4
20 252.7±31.4⁎ 65.0±9.2
0 6.3±3.1 2.0±1.1
Resting 6 69.0±45.0 6.5±3.0
20 55.9±28.8 8.3±2.0
0 124.9±19.5 35.8±3.7
Rearing 6 126.3±40.0 32.3±5.6
20 93.4±11.8 32.3±3.6
0 197.1±48.4 36.0±4.0
Snifﬁng 6 169.5±18.1 37.1±5.0
20 305.1±34.0 60.3±6.5⁎
0 62.1±13.9 6.6±1.4
Grooming 6 75.6±11.3 4.5±0.5
20 112.8±23.0 9.3±1.7
Values are mean±S.E.M.
⁎ pb0.05 as compared to the vehicle treatment (one-way ANOVA followed by Duncan'sTaken together, these data suggest that α1-adrenergic receptors within
the MnR seem to speciﬁcally participate in the control of food intake.
We have previously shown that injection of AD into the MnR of
free-feeding rats decreased the latency to start drinking [39]. These
data suggest the involvement of MnR adrenergic receptors in circuitsE) or clonidine (CLON) into the median raphe nucleus of overnight fast . The number of
Clonidine (CLON)
in)
Dose
(nmol/0.2 μl)
Duration (s) Frequency
(turn number/30 min)
0 145.1±15.6 41.6±4.2
6 181.5±14.7 51.4±3.2
20 183.3±26.7 46.2±6.5
0 26.1±11.5 7.3±2.7
6 12.9±3.7 4.7±1.4
20 12.7±4.3 4.3±1.2
0 77.2±8.6 28.2 ±2.3
6 95.6±14.1 33.0±3.6
20 91.6±13.9 28.2±4.3
0 104.3±11.5 31.0±3.4
6 131.8±15.2 34.9±4.1
20 142.3±38.2 33.2±7.5
0 43.1±15.1 4.0±1.5
6 87.2±18.2 4.7±0.5
20 54.3±12.0 3.3±0.5
post-hoc test).
Fig. 5. Changes on food intake, feeding latency, feeding duration and feeding frequency after injection of vehicle (0) or clonidine (CLON, 6 nmol and 20 nmol) into the median raphe
nucleus (MnR) of overnight fast. Values are mean±S.E.M. Numbers in parentheses indicate the number of animals per group.
227A.S. Ribas et al. / Physiology & Behavior 105 (2012) 220–229controlling water intake. The present results exclude the participation
of α-adrenergic receptors within the MnR in the control of water in-
take since treatment with either α1- or α2-adrenergic receptor ago-
nists in the MnR failed to affect drinking behaviour. Furthermore,
the adrenergic control of drinking and feeding behaviours seems to
include separate circuits in the MnR since α1-adrenergic receptor ac-
tivation in this nucleus increased food intake but was not associated
with changes in drinking behaviour.
In conclusion, the present results reinforce the inhibitory func-
tional role of α1-adrenergic receptors within the MnR on feedingFig. 6. Changes on food intake after injection of vehicle (0) or phenylephrine (PHE, 20 nmo
stricted rats (15 g chow/day during 7 days) (A) and overnight fast rats (B). Values are mean±
in the non-MnR (two-way ANOVA followed by Duncan's test for multiple comparisons). Nubehaviour. This inhibitory inﬂuence tonically restrains food intake
under free-feeding conditions since MnR α1-adrenergic receptor
blockade increased food intake in rats with free access to lab chow
[47]; the intensity of this inhibitory mechanism seemed to decline
as food availability decreased.
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